Privia Health Group, Inc. (PRVA)

Nasdaq Health Care Health Care Services S&P SmallCap 600
$24.42
+0.48 (+2.01%)
Close of Nov 06, 2026 · end-of-day data
Next earnings date
Not scheduled yet
No report date announced in the next three weeks.
Consensus EPS estimate
—
Shown once a date is announced.
Last report (Nov 05)
$0.10 vs $0.09 est.
Surprise +11.1%

Earnings surprise history

reported EPS vs consensus
ReportedQuarterEPS estimateReported EPSSurprise
Nov 05, 2026Sep/2026$0.09$0.10+11.1%

Our record of PRVA's reports since we began tracking; it grows each quarter.

Latest results, in brief

All PRVA 8-K briefs →
Nov 5, 6:10 AM ET

Privia Health raises 2026 guidance after Q3 revenue rises 13.2% to $657.0 million

Positive guidance 2.02

Privia Health reported third-quarter 2026 revenue of $657.0 million, up 13.2% from a year earlier, and net income attributable to the company of $13.5 million, up from $6.9 million. The company raised its full-year 2026 guidance, including Adjusted EBITDA of $154 million to $157 million, up from the initial range of $145 million to $155 million. It also agreed to acquire American Choice Healthcare MSSP for approximately $36 million in cash and will exit its Montana partnership effective January 2027.

  • Q3 2026 total revenue was $657.0 million, up from $580.4 million; diluted net income per share was $0.10, up from $0.05.
  • Updated FY 2026 Adjusted EBITDA guidance is $154 million to $157 million, versus initial guidance of $145 million to $155 million given February 27, 2026.
  • Updated FY 2026 GAAP revenue guidance is $2,500 million to $2,550 million, versus initial guidance of $2,350 million to $2,450 million.
  • Cash and cash equivalents were $446.3 million at September 30, 2026, with no debt; the company expects at least $520 million in year-end cash including the acquisition.
Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.

Quarter endedRevenueYoYEPS (diluted)YoYNet incomeNet margin
Sep 2026$656.96M+13.2% $0.10+100.0% $13.49M2.1%
Jun 2026$632.63M+21.4% $0.07+250.0% $9.05M1.4%
Mar 2026$603.85M+25.8% $0.02-33.3% $3.06M0.5%
Dec 2025$541.17M+17.4% $0.07+133.3% $9.15M1.7%
Sep 2025$580.42M+32.5% $0.05+66.7% $6.86M1.2%
Jun 2025$521.15M+23.4% $0.02-33.3% $2.69M0.5%
Mar 2025$480.10M+15.6% $0.03+50.0% $4.22M0.9%
Dec 2024$460.90M+4.6% $0.03+0.0% $4.40M1.0%

From Privia Health Group, Inc.'s 10-Q and 10-K filings (SEC XBRL). YoY compares each quarter with the same quarter a year earlier; it is blank when the year-ago figure is missing or negative.

Annual results

Fiscal yearRevenueGrowthEPS (diluted)GrowthNet margin
FY2025$2.12B+22.3% $0.18+63.6%1.1%
FY2024$1.74B+4.7% $0.11-42.1%0.8%
FY2023$1.66B+22.2% $0.19—1.4%
FY2022$1.36B+40.4% $-0.08—-0.6%
FY2021$966.22M+18.3% $-1.83-654.5%-19.5%

Frequently asked questions

When is Privia Health Group's next earnings date?

Privia Health Group has not announced a report date within the next three weeks. US companies usually report three to six weeks after each quarter ends; this page updates as soon as the date is on the calendar.

What did Privia Health Group earn last quarter?

For the quarter ended Sep 2026, Privia Health Group reported diluted EPS of $0.10 (+100.0% year over year) on revenue of $656.96M (+13.2%).

Where do these numbers come from?

Reported revenue, net income and EPS come from the company's own 10-Q and 10-K filings with the SEC (XBRL data). The report date and consensus estimate come from the Nasdaq earnings calendar.

Not investment advice. Figures can be restated by the company in later filings.